HealthPlix, an online healthcare startup based in Bengaluru has secured funds amounting to $3 million in a Series A funding round. This round was led by IDG Ventures and Kalaari Capital.
Post the round, the company will utilize the funds in strengthening its technology and grow its medical specialties. The company aims to bring a transformation in the way diseases are treated in the Indian outpatient care.
The startup was founded in 2014 by Raghuraj Sunder Raju, Sandeep Gudibanda and Prasad Basavaraj, which at present, claims to provide services across 20 states and 130 cities in India. It caters in specialties including Diabetology, Cardiology, Nephrology, Endocrinology, Oncology and Internal Medicine.
Most of the queries received by the company are from Maharashtra which is further followed by other regions like West India, South and then North India. The startup basically operates an app, which is separate for patients and a separate app for doctors. This helps to achieve personalization at scale for the doctors. The online platform provides various facilities such as e-prescription, lab, billing, dashboards etc.
“60% of our prescriptions happen in regional languages. Based on patient’s regional language, the prescription will come out in his/her preferred language. At present, the company is supporting 22 languages which include Hindi, Marathi, Tamil, Urdu, Telugu among others,” said Sandeep Gudibanda.
The patients can pay to the doctor in both ways, offline as well as online. The payments of different doctors vary with specialty ranging from Rs 20K to Rs 1 Lakh. The company offers its model as a software on which a doctor can write a prescription in 30 seconds and the other option is the physical protocol technique, where doctors take a snapshot and understand about the patient.
The company wants to add value to its platform and make India healthy, therefore, its focus is to make sure that a doctor runs his own clinic and own pharmacy. The healthcare market in India is currently worth $100 billion, and it is further expected to reach the valuation of $280 billion by 2020.